Evio, Inc. (“Evio”): Quinsam expects to close today an investment of US$450,000 in units of convertible debentures and warrants in the capital of Evio. The debentures convert at US$0.60 and the warrants strike at US$0.80. The common shares are currently trading at approximately US$2.15. Evio is an operator of cannabis testing labs in the United States. We anticipate that Evio will pursue a Canadian listing.